X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $88,709.22 +1.07%
Ethereum $2,959.71 +0.48%
BNB $838.10 -0.76%
Optimism $0.26 +0.05%
Arbitrum $0.19 +0.81%
Solana $122.57 -0.12%
Polygon $0.22 +2.77%
Cosmos $2.04 +2.42%
Avalanche $12.48 +2.63%

Bitcoin $88,709.22 +1.07%
Ethereum $2,959.71 +0.48%
BNB $838.10 -0.76%
Optimism $0.26 +0.05%
Arbitrum $0.19 +0.81%
Solana $122.57 -0.12%
Polygon $0.22 +2.77%
Cosmos $2.04 +2.42%
Avalanche $12.48 +2.63%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed